Scholarlink

<p>Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease associated with motor neuron death. Superoxide dismutase 1 (SOD1) misfolding and aggregation have been linked to familial and sporadic ALS, where either mutant or wild-type SOD1 species abnormally accumulate as observed in postmortem tissue of ALS cases. These SOD1 species are toxic and contribute to motoneuron cell death. A dysregulation of the autophagy pathway has been widely observed in ALS. Previously, we found that Rubicon, a negative regulator of autophagy and endocytosis was upregulated in postmortem spinal cord tissue from sporadic ALS patients and in two ALS mouse models during the symptomatic stage of the disease. Here we found that overexpression of Rubicon in a motoneuron cell line led to marked increase in mutant SOD1 aggregation. Hence, we investigated the effects of Rubicon loss of function in the context of the SOD1<sup>G93A</sup> ALS mouse model on disease progression and outcome. SOD1<sup>G93A</sup>/Rub<sup>−/−</sup> mice exhibited an earlier disease onset and shorter lifespan than did littermate SOD1<sup>G93A</sup>/Rub<sup>+/+</sup> mice. Although we observed motor function loss in phenotypic analyses, no changes in microgliosis, astrogliosis, the number of motor neurons or levels of misfolded SOD1 aggregates were detected <i>in vivo</i>. Nevertheless, <i>in vitro</i> experiments showed Rubicon loss-of function in a motor neuron cell line increased mutant SOD1 aggregation, just like its overexpression, however with no adverse effect on motor neuron viability. These results suggest that Rubicon loss-of-function has unforeseen detrimental effects <i>in vivo</i>, highlighting a requirement for a cell-type specific fine-tuned balance of autophagy regulators.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Systemic loss of Rubicon aggravates pathological features in the SOD1G93A mouse model

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月22日

查看全文
  • Leonardo Rodriguez,
  • Patricia Ojeda,
  • Sebastian Beltran,
  • Ernesto Muñoz-Palma,
  • Diego Rojas-Rivera,
  • Cristian A. Bergmann,
  • Fernanda Hernandez,
  • Danilo B. Medinas,
  • Patricio A. Manque,
  • Ute Woehlbier

摘要

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease associated with motor neuron death. Superoxide dismutase 1 (SOD1) misfolding and aggregation have been linked to familial and sporadic ALS, where either mutant or wild-type SOD1 species abnormally accumulate as observed in postmortem tissue of ALS cases. These SOD1 species are toxic and contribute to motoneuron cell death. A dysregulation of the autophagy pathway has been widely observed in ALS. Previously, we found that Rubicon, a negative regulator of autophagy and endocytosis was upregulated in postmortem spinal cord tissue from sporadic ALS patients and in two ALS mouse models during the symptomatic stage of the disease. Here we found that overexpression of Rubicon in a motoneuron cell line led to marked increase in mutant SOD1 aggregation. Hence, we investigated the effects of Rubicon loss of function in the context of the SOD1G93A ALS mouse model on disease progression and outcome. SOD1G93A/Rub−/− mice exhibited an earlier disease onset and shorter lifespan than did littermate SOD1G93A/Rub+/+ mice. Although we observed motor function loss in phenotypic analyses, no changes in microgliosis, astrogliosis, the number of motor neurons or levels of misfolded SOD1 aggregates were detected in vivo. Nevertheless, in vitro experiments showed Rubicon loss-of function in a motor neuron cell line increased mutant SOD1 aggregation, just like its overexpression, however with no adverse effect on motor neuron viability. These results suggest that Rubicon loss-of-function has unforeseen detrimental effects in vivo, highlighting a requirement for a cell-type specific fine-tuned balance of autophagy regulators.